Context Active surveillance (AS) is an alternative to initial radical treatment of low-risk
prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some …

Abstract Background The Prostate Cancer Research International Active Surveillance
(PRIAS) study was initiated a decade ago to study the most optimal selection and follow-up …

BACKGROUND: Overdiagnosis and subsequent overtreatment are important side effects of
screening for, and early detection of, prostate cancer (PCa). Active surveillance (AS) is of …

Background Prostate cancer is a major public health problem with considerable
uncertainties about the effectiveness of population screening and treatment options. We …

The past few decades have seen considerable advances in the way cancer is diagnosed
and treated. Yet with the growing prevalence of cancer and ongoing pressures on limited …

Overtreatment of low-grade prostate cancer (Gleason score6) is a recognized problem
today, with systematic prostate gland sampling triggered by prostate-specific antigen (PSA) …

Background Men with prostate cancer on active surveillance (AS) are advised to follow strict
follow-up schedules and switch to definitive treatment on risk reclassification. However …

Purpose: Active surveillance is the preferred management of low risk prostate cancer.
Cancer specific anxiety during active surveillance remains under studied. We evaluated …

Objective To test the expandability of active surveillance (AS) to Gleason score 3+ 4 cancers
by assessing the unfavorable disease risk in a large multi-institutional cohort. Materials and …

Objective To assess, in men undergoing active surveillance (AS) for low‐risk prostate
cancer, whether saturation or transperineal biopsy altered oncological outcomes, compared …